Keryx biopharmaceuticals inc (KERX)
CashFlow / Quarterly
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net loss

-16,995

-21,518

-21,896

-30,429

-23,498

-86,497

-23,016

-33,784

-41,696

-44,651

-40,964

-37,784

-30,745

-26,877

-27,739

-40,285

-35,289

-22,414

-13,530

-17,668

-15,651

-11,358

-2,055

-6,628

-5,475

-1,504

-9,114

-8,375

-10,247

-3,096

-6,405

Adjustments to reconcile net loss to cash flows used in operating activities:
Stock-based compensation expense

3,864

4,973

3,680

7,565

3,371

3,672

3,664

3,426

3,717

3,553

3,293

3,550

4,575

4,054

4,321

13,561

8,240

2,604

2,552

3,993

741

638

581

538

545

438

646

528

472

519

573

Amortization of debt discount

-

-

-

-

-

-

-

1

0

18,478

15,748

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liability

-

-

-

-

-

-

-

0

0

2,711

2,007

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

251

224

252

248

230

230

229

229

256

259

261

165

148

145

138

121

97

56

32

20

12

12

10

-

-

-

-

-

-

-

-

Amortization of deferred lease incentive

61

61

62

60

62

60

62

61

61

61

61

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-down of inventory to net realizable value

1,793

1,191

4,097

1,796

1,336

110

225

11,616

13,616

2,736

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

0

0

-635

-295

21

19

20

20

20

20

20

23

22

23

22

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

-

12

10

11

Other current assets

-218

1,012

-1,610

-4,353

6,916

-1,017

6,483

-223

1,317

-443

-311

-1,459

1,520

-571

-752

1,349

1,588

-90

13

-2,439

2,417

-490

1,314

-128

368

-334

-10

-270

436

225

-57

Accounts receivable, net

-824

2,541

4,743

-1,052

739

2,306

917

5,236

-5,101

776

669

1,028

1,190

155

449

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

12,205

15,806

8,710

-

7,162

5,611

-928

-

-1,660

4,179

-371

-

1,508

6,694

19,317

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in security deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

50

1

Other assets

5,586

-286

3,441

8,439

36

-97

88

11

0

0

0

-

-

-

-

116

0

-41

-64

60

58

0

-35

-

-

-

-

0

0

-17

38

Accrued interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-103

15

-59

195

-

-

-

-

0

-38

-29

60

-

-

-

-

Other current liabilities

7

6

7

7

7

7

7

117

-15

-78

-262

-

-

-

-15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

2,335

11,624

-3,551

11,705

4,330

8,425

-437

3,401

-1,578

6,449

-8,184

-6,121

285

-11,565

8,923

2,435

7,912

1,271

1,951

-1,859

4,465

2,944

1,242

87

-1,740

-694

689

-303

3,023

-11

883

Accrued compensation and related liabilities

-

-

-

-

-

-

-

-

-

-

-

-

379

1,487

-2,178

-

1,702

871

-910

692

210

220

-625

265

144

240

-719

394

150

175

-491

Deferred revenue

-

-

-

-

-

-

-

0

-3,358

-360

192

1,541

456

815

300

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-44

-45

-38

-38

-38

-37

-33

-141

-53

-51

209

429

336

212

-34

58

-3

37

3

38

-12

-12

-12

36

-11

-13

-11

-

-12

-12

-11

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,566

-6,848

-3,800

-8,549

-7,625

-7,095

-2,680

-5,422

Net cash used in operating activities

-

-

-33,430

-

-

-

-25,963

-20,352

-23,654

-14,870

-27,728

-24,589

-28,822

-38,770

-35,276

-33,598

-19,786

-17,571

-10,046

-12,249

-12,640

-7,292

-2,138

-

-

-

-

-

-

-

-

Cash flows from investing activities
Purchases of property, plant and equipment

0

-26

78

81

756

420

0

10

24

3

2,037

2,345

268

103

61

290

413

565

221

297

4

0

45

5

16

1

2

9

14

9

25

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5

5,996

3,200

-5,003

5,043

39

-9,125

-125

Investment in held-to-maturity short-term securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

46

4,454

-4,501

49,772

-

-

-

-

0

0

6,027

5,236

201

200

9,340

200

Proceeds from maturity of held-to-maturity short-term securities

-

-

-

-

-

-

-

-

-

-

-

0

0

0

11,508

22,639

15,344

173

107

-

-

-

-

0

6,012

9,228

235

5,253

253

224

100

Net cash used in investing activities

-

-

-78

-

-

-

0

-10

-24

-3

-2,037

-2,345

-268

-103

11,447

22,303

10,477

4,109

-49,886

-297

24,290

-24,294

-45

-

-

-

-

-

-

-

-

Cash flows from financing activities
Proceeds from issuance of common stock, net of commission

0

0

0

-2

2,597

68,045

5,080

0

0

0

0

0

0

0

118,284

-

-

-

-

-

-

-

80,393

-

-

-

-

-

-

-

-

Gross proceeds from public offerings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

115,057

-

-

-

-

-

-

-

-

-

-

-

-

Payments for common stock issuance costs

0

0

0

0

14

60

28

0

0

0

0

-

-

-

-

-

0

65

7,460

0

0

3

5,637

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

73

708

69

88

801

247

10

0

54

138

6

16

9

1,341

97

1,447

1,447

264

1,896

504

209

125

93

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

69

-

-

-

5,062

0

54

138

6

125,016

9

1,326

118,381

1,447

1,447

199

109,493

504

209

122

74,849

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,681

32,149

0

Net (decrease) increase in cash and cash equivalents

-8,312

-10,629

-33,439

-20,473

-26,528

49,618

-20,901

-20,362

-23,624

-14,735

-29,759

98,082

-29,081

-37,547

94,552

-9,848

-7,862

-13,263

49,561

-12,042

11,859

-31,464

72,666

-5,571

-852

-600

-13,552

-2,582

-5,375

20,344

-5,547